ThinkSabio

$AKBA

$0.90▲ -2.2% YTD

4 SEC 13D/G filings tracked · Last updated Oct 6, 2026

Filing History
News
AKBA ▼ -2.2% - Akebia Therapeutics, Inc.
CP $0.90▲ -2.2%Oct 6, 2026 · ThinkSabio Blog

$AKBA - Akebia Therapeutics Announces Late-Breaking VOICE Trial Presentation and Posters on Akebia’s Rare Kidney Pipeline at ASN Kidney Week 2026…

News
AKBA ▼ -4.3% - Akebia Therapeutics, Inc.
CP $0.88▲ -4.3%Oct 1, 2026 · ThinkSabio Blog

$AKBA - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…

News
AKBA ▲ +1.1% - Akebia Therapeutics, Inc.
CP $0.96▲ +1.1%Sep 14, 2026 · ThinkSabio Blog

$AKBA - Akebia Therapeutics Announces First Patient Dosed in Phase 2 Basket Trial of Ebribafusp in Rare Complement-Mediated Kidney Diseases…

News
AKBA ▲ +3.3% - Akebia Therapeutics, Inc.
CP $0.95▲ +3.3%Sep 1, 2026 · ThinkSabio Blog

$AKBA - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)…